Search Within

Epidemiology and Biostatistics

Formats
  1. Journal Article (6498)
  2. Meeting Abstract (3316)
  3. Editorial (119)
  4. Review (95)
  5. Research Letter (84)
  6. Correspondence (80)
  7. Conference Paper (55)
  8. Miscellaneous (53)
  9. Book Section (45)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Biostatistics Service (6660)
  2. Department of Medicine (5011)
  3. Population Sciences Research Program (4940)
  4. Surgery (3714)
  5. Survivorship Research (3652)
  6. Solid Tumor Oncology Division (3356)

More Groups

People
  1. Mithat Gonen (1033)
  2. Andrew Vickers (890)
  3. Sean Devlin (615)
  4. Katherine Panageas (519)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (491)

More People

Years
  1. 2025 (319)
  2. 2024 (666)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1401)
  2. Blood (578)
  3. Annals of Surgical Oncology (464)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (259)
  6. Clinical Cancer Research (252)

More Publications

Publishers
  1. American Society of Clinical Oncology (1517)
  2. Elsevier Inc. (1212)
  3. Springer (930)
  4. American Association for Cancer Research (766)
  5. Elsevier Science, Inc. (692)
  6. American Society of Hematology (647)

More Publishers

Results (10363)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population priors for matrix factorization
    Journal Article

    Salehi, S.; Nazaret, A.; Shah, S. P.; Blei, D. M.
    Transactions on Machine Learning Research (2024)

    Fulltext@MSK | Save
  • Role of PD-1hiFoxp3-CD4+tumor-infiltrating lymphocytes in the immunotherapy response
    Meeting Abstract

    Zappasodi, R.; Mangarin, L. M.; Martis, S.; Orlando, A.; Schad, S.; Wolchok, J. D.; Greenbaum, B.; Merghoub, T.
    Cancer Science (2024)

    Fulltext@MSK | Save
  • Comparison of acute kidney injury in patients with relapsed or refractory multiple myeloma following CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Farzana, T.; Shaikh, A.; Latcha, S.; Gutgarts, V.; Jurgens, E. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Body mass index trajectory during triplet induction therapy: Clinical implications in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R. S.; Derkach, A.; Furberg, H.; Shekarkhand, T.; Rueda, C.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Proteolytic control and therapeutic targeting of oncogenic gene expression in acute myeloid leukemia
    Meeting Abstract

    Uni, M.; Steinberg, A. P.; Slavit, A.; Rha, S.; Cheng, S.; Schmalbrock, L. K.; Su, J.; Ma, J.; McPherson, A.; Mullighan, C. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Developing an optimal fully-human CD371-targeting IL-18 secreting CART cell for the treatment of acute myeloid leukemia
    Meeting Abstract

    Shahid, S.; Mathew, S.; Souness, S.; Burns, E. R.; Um, J. S.; Yoo, S.; Cai, W.; Pohl, M. A.; Fujino, T.; Zhang, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Large-scale transcriptome analysis supports genomic taxonomy and predicts response to hypomethylating agents in myelodysplastic neoplasms
    Meeting Abstract

    Todisco, G.; Zampini, M.; Moura, P. L.; Buizza, A.; Mortera-Blanco, T.; Tranberg, A.; Riva, E.; Creignou, M.; Campagna, A.; Ubezio, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique response to intensive induction chemotherapy, suggesting futility of mid-cycle bone marrow biopsy and caution when considering re-induction
    Meeting Abstract

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save